01 3Gowling Lafleur Henderson LLP
02 5McCarthy Tétrault
01 12086874
02 12132936
03 12155947
04 12189916
05 12267498
06 12294981
07 12509365
08 12512487
01 3Paclitaxel
02 5paclitaxel
01 5Powder for Suspension
02 3liquid IV
01 12013-01-07
02 12014-02-22
03 12014-09-26
04 12016-11-08
05 22017-09-24
06 12018-06-26
07 12023-12-09
Patent Expiration Date : 2014-02-22
Date Granted : 2007-08-21
Brand Name : ABRAXANE FOR INJECTABLE SUSPENSION
Patent Number : 2155947
Filing Date : 1994-02-22
Strength per Unit : 100 mg / vial
Dosage Form : Powder for Suspension
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-02-22
Date Granted : 2007-08-21
Patent Expiration Date : 2018-06-26
Date Granted : 2012-04-03
Brand Name : ABRAXANE FOR INJECTABLE SUSPENSION
Patent Number : 2294981
Filing Date : 1998-06-26
Strength per Unit : 100 mg / vial
Dosage Form : Powder for Suspension
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2018-06-26
Date Granted : 2012-04-03
Patent Expiration Date : 2017-09-24
Date Granted : 2007-05-08
Brand Name : ABRAXANE FOR INJECTABLE SUSPENSION
Patent Number : 2267498
Filing Date : 1997-09-24
Strength per Unit : 100 mg / vial
Dosage Form : Powder for Suspension
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-09-24
Date Granted : 2007-05-08
Patent Expiration Date : 2017-09-24
Date Granted : 2012-05-29
Brand Name : ABRAXANE FOR INJECTABLE SUSPENSION
Patent Number : 2512487
Filing Date : 1997-09-24
Strength per Unit : 100 mg / vial
Dosage Form : Powder for Suspension
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-09-24
Date Granted : 2012-05-29
Patent Expiration Date : 2023-12-09
Date Granted : 2012-08-07
Brand Name : ABRAXANE FOR INJECTABLE SUSPENSION
Patent Number : 2509365
Filing Date : 2003-12-09
Strength per Unit : 100 mg / vial
Dosage Form : Powder for Suspension
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2023-12-09
Date Granted : 2012-08-07
Patent Expiration Date : 2013-01-07
Date Granted : 1998-09-01
Brand Name : TAXOL
Patent Number : 2086874
Filing Date : 1993-01-07
Strength per Unit : 6mg / ml
Dosage Form : liquid IV
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-01-07
Date Granted : 1998-09-01
Patent Expiration Date : 2014-09-26
Date Granted : 1999-06-29
Brand Name : TAXOL
Patent Number : 2132936
Filing Date : 1994-09-26
Strength per Unit : 6mg / ml
Dosage Form : liquid IV
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-09-26
Date Granted : 1999-06-29
Patent Expiration Date : 2016-11-08
Date Granted : 2001-01-01
Brand Name : TAXOL
Patent Number : 2189916
Filing Date : 1996-11-08
Strength per Unit : 6mg / ml
Dosage Form : liquid IV
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-11-08
Date Granted : 2001-01-01
LOOKING FOR A SUPPLIER?
Market Place
